| Product |
CAS |
Molecular formula |
More |
| Levocabastine related compound a (50 mg) (1-[cis-4-cyano-4-(4-fluoroph |
80139-91-9 |
C25H27FN2O2.HCL |
More |
| (S)-n-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)et |
216868-57-4 |
C16H20FN3O3S |
More |
| Lisinopril s,s,s-diketopiperazine |
328385-86-0 |
C21H29N3O4 |
More |
| Lorazepam related compound d (25 mg) (6-chloro-4-(o-chlorophenyl)-2-qu |
54643-79-7 |
C15H8Cl2N2O2 |
More |
| Loxapine related compound a (20 mg) (3-chloro-11-(4-methylpiperazin-1- |
3454-96-4 |
C18H18ClN3O |
More |
| Laureth-4 |
68439-50-9 |
C14H30O |
More |
| Magaldrate |
74978-16-8 |
Al5H31Mg10O39S2.xH2O |
More |
| Maprotiline related compound d |
38849-14-8 |
C20H22ClN |
More |
| Mecamylamine related compound a (10 mg) (n,1,7,7-tetramethyl bicyclo |
22321-23-9 |
C11H21N.ClH |
More |
| Fish oil |
8002-50-4 |
NULL |
More |
| Meprylcaine hydrochloride (200 mg) |
956-03-6 |
C14H22ClNO2 |
More |
| Metformin related compound b (25 mg) (1-methylbiguanide hydrochloride) |
1674-62-0 |
C3H10ClN5 |
More |
| 2-Propenoic acid, 2-methyl-, polymer with ethyl 2-propenoate |
25212-88-8 |
(C5H8O2•C4H6O2)x |
More |
| Methantheline bromide (200 mg) |
53-46-3 |
CH3- |
More |
| Methicillin sodium (500 mg) (as) |
7246-14-2 |
C17H21N2NaO7S |
More |
| L-glutamic acid, n-[4-[[ (2-amino-1, 4-dihydro-4-oxo-6-pteridinyl)meth |
2410-93-7 |
C20H21N7O6 |
More |
| Methotrexate related compound e (50 mg) (4-{[(2,4-diaminopteridin-6-yl |
70844-48-3 |
C20H21N7O6 |
More |
| (-)-10-(3-[Dimethylamino]-2-methylpropyl)-2-methoxy-phenothiazine male |
60-99-1 |
C23H28N2O5S |
More |
| Methylenedioxy-3,4-amphetamine hydrochloride ci (25 mg) (as) (mda) |
6292-91-7 |
C10H14ClNO2 |
More |
| N-[(2e)-6,6-dimethyl-2-hepten-4-yn-1-yl]-n,4-dimethyl-1-naphthalenemet |
877265-33-3 |
C22H28ClN |
More |
